Alexander D MacKerell, Jr
Inventor
Stats
- 6 US patents issued
- 25 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 6 US Patents Issued
- 25 US Applications Filed
- 89 Total Citation Count
- Dec 5, 2024 Most Recent Filing
- Mar 29, 2006 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 1
| 2006
|
| UNIVERSITY OF MARYLAND, BALTIMORE | 2
1 1 4 4 | 2007
2010 2011 2013 2015 |
| UNIVERSITY OF MARYLAND, BALTIMORE A CONSTITUENT INSTITUTION OF THE UNIVERSITY | 1
| 2011
|
| UNIVERSITY OF MARYLAND, BALTIMORE, A CONSTITUENT INSTITUTION OF THE UNIVERSITY SYSTEM OF MARYLAND | 1
| 2007
|
| BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 1
1 | 2007
2011 |
| ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. | 2
| 2007
|
| CASE WESTERN RESERVE UNIVERSITY | 2
| 2010
|
| LINO MANFROTTO + CO. S.P.A. | 2
| 2013
|
| UNIVERSITY HEALTH NETWORK | 1
| 2007
|
Inventor Addresses
| Address | Duration |
|---|---|
| Baltimore, MD, US | Dec 03, 09 - Mar 27, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 13 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 9 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0100,985 | 2025 | NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS | 0 |
| 12202810 | 2025 | Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors | 0 |
| 2024/0366,619 | 2024 | NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF | 0 |
| 2024/0132,484 | 2024 | BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX | 0 |
| 11911392 | 2024 | Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.